Method of treatment for myocardial infarction
US5275812A · kind A · utility
Assignees
Inventors
Key dates
| Filing date | Feb 25, 1993 |
| Grant date | Jan 4, 1994 |
| Priority date | — |
| Expiry date | Feb 25, 2013 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2123/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a novel treatment for myocardial infarction which comprises administering a hapten-binding molecule capable of preventing reformation of fibrin-platelet clots and a thrombolytic agent capable of either dissolving fibrin-platelet clots or inhibiting their formation. The therapy of the invention is capable of increasing clot lysis while minimizing fibrinogen breakdown and preventing the reocclusion of the affected coronary artery. The therapy of the present invention is capable of achieving this goal even in the absence of heparin and when the concentration of thrombolytic agent is lower than that required by other potential therapies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.